Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Hepatogastroenterology ; 51(57): 652-7, 2004.
Article in English | MEDLINE | ID: mdl-15143885

ABSTRACT

BACKGROUND/AIMS: Use of endoscopic papillary balloon dilation (EPBD) for the treatment of common bile duct stones has increased in recent years, owing to its simplicity and its advantage of preserving sphincter function. It has been reported that EPBD is associated with a lower risk of bleeding, but a higher risk of pancreatitis than endoscopic sphincterotomy. However, there have been few reports on studies of post-EPBD pancreatitis. This report concerns the use of EPBD at our department for the treatment of common bile duct stones and early postoperative complications, with a focus on pancreatitis. METHODOLOGY: The study was conducted in 63 patients with choledocholithiasis, including 4 patients with cirrhosis and 21 patients with periampullary diverticula. The stones were extracted after EPBD conducted with an 8-mm dilatation balloon. RESULTS: Complete removal of stones was achieved in 53 out of 63 patients (84.1%). Pancreatitis meeting the criteria of Cotton et al. occurred in 7 of the 63 patients (11.1%), while 12 patients (19.5%) were affected when milder cases of pancreatitis were included. Severe pancreatitis occurred in 1 patient only. Cholangitis occurred in 3 patients (4.8%) and basket impaction occurred in 1 patient (1.6%), but no serious complications such as bleeding or perforation were encountered. CONCLUSIONS: These results suggest that EPBD is an effective procedure for the treatment of common bile duct stones, with a low risk of serious complications.


Subject(s)
Catheterization , Gallstones/therapy , Adult , Aged , Aged, 80 and over , Ampulla of Vater , Female , Humans , Male , Middle Aged , Postoperative Complications/etiology
2.
FEBS Lett ; 558(1-3): 33-8, 2004 Jan 30.
Article in English | MEDLINE | ID: mdl-14759512

ABSTRACT

Trefoil factor family (TFF) is a group of peptides that play critical roles in maintaining gastric mucosal integrity. In real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) and reporter gene assays, we show that indomethacin and aspirin upregulate TFF2 expression in MKN45 gastric cells. These drugs also activated peroxisome proliferator-activated receptor gamma (PPARgamma) at concentration ranges that increase TFF2 expression, and upregulated TFF2 expression was suppressed by GW9662, a specific inhibitor of PPARgamma. These results suggest that indomethacin and aspirin upregulate gastric expression of TFF2 through activation of PPARgamma. This mechanism may be important in reducing the extent of gastric mucosal injury caused by the administration of non-steroidal anti-inflammatory drugs (NSAIDs).


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Epithelial Cells/metabolism , Mucins , Muscle Proteins , Neuropeptides , Peptides/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Transcription Factors/metabolism , Up-Regulation/drug effects , Anilides/pharmacology , Aspirin/pharmacology , Cell Line, Tumor , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Epithelial Cells/drug effects , Gene Expression Regulation, Neoplastic , Genes, Reporter , Humans , Indomethacin/pharmacology , RNA, Messenger/metabolism , Receptors, Cytoplasmic and Nuclear/genetics , Reverse Transcriptase Polymerase Chain Reaction , Stomach Neoplasms/pathology , Transcription Factors/genetics , Transcription, Genetic/drug effects , Transcriptional Activation/drug effects , Trefoil Factor-2 , Trefoil Factor-3
3.
Am J Hematol ; 74(4): 287-9, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14635213

ABSTRACT

We report a case of diffuse follicular center lymphoma (FCL), which is a morphological variant of follicular lymphoma, resembling multiple lymphomatous polyposis (mantle cell lymphoma of the intestine). The patient was a 48-year-old Japanese man who was found, by colonoscopy, to have numerous small polypoid lesions along the entire large intestine. Abdominal computed tomography revealed hepatosplenomegaly and enlargement of multiple mesenteric lymph nodes. Histologically, the lesion was characterized by diffuse proliferation of small- to medium-sized lymphocytes with cleaved nuclei in the mucosa and submucosa. Immunohistochemical studies showed that the tumor cells were CD20+, CD10+, BCL-2+, CD5-, surface IgM-, and cyclin D1-. Moreover, a cytogenetic study showed a translocation at (14;18)(q32;q21). Finally, this case was diagnosed as diffuse FCL, although the tumor was mimicking mantle cell lymphoma.


Subject(s)
Intestinal Neoplasms/diagnosis , Lymphoma, Follicular/diagnosis , Lymphoma, Mantle-Cell/diagnosis , Chromosomes, Human, Pair 14 , Chromosomes, Human, Pair 18 , Colonography, Computed Tomographic , Colonoscopy , Diagnosis, Differential , Humans , Immunohistochemistry , Immunophenotyping , Lymphocytes/pathology , Lymphoma, Large B-Cell, Diffuse/diagnosis , Male , Middle Aged , Translocation, Genetic
4.
Int J Surg Pathol ; 10(4): 297-302, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12490983

ABSTRACT

Diffuse nodular lymphoid hyperplasia (DNLH) of the intestine is an extremely rare lymphoproliferative disorder occasionally associated with non-Hodgkin lymphomas. We report an unusual case of DNLH of the entire colon, which resembled malignant lymphoma (particularly low-grade B-cell lymphoma) both on clinical and pathologic grounds. The patient was a 62-year-old Japanese woman who was found to have multiple polypoid lesions along the entire large intestine by colonoscopy. Abdominal computed tomography revealed hepatosplenomegaly and multiple mesenteric lymphadenopathy. Histologically, the lesion was characterized by numerous lymphoid follicles with active germinal centers and a diffuse infiltrate of lymphoid cells in the mucosa and submucosa. The present case appears to be an essentially benign condition bearing a resemblance, both clinically and histologically, to malignant lymphoma, and from which it can be distinguished by use of immunohistochemical or molecular analysis.


Subject(s)
Agammaglobulinemia , Colon/pathology , Gastrointestinal Diseases/pathology , Lymph Nodes/pathology , Lymphoproliferative Disorders/pathology , Malabsorption Syndromes , Agammaglobulinemia/complications , Agammaglobulinemia/pathology , Biomarkers/analysis , Diagnosis, Differential , Female , Gastrointestinal Diseases/complications , Gastrointestinal Diseases/genetics , Humans , Hyperplasia/pathology , Immunoenzyme Techniques , Karyotyping , Lymphoma, B-Cell/pathology , Lymphoproliferative Disorders/complications , Lymphoproliferative Disorders/genetics , Malabsorption Syndromes/complications , Malabsorption Syndromes/pathology , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...